Background: Th e current gold standard for the diagnosis of celiac sprue is histopathologic fi ndings on small bowel biopsies. Th ree serologic markers, anti-gliadin antibody (AGA), anti-tissue transglutaminase antibody (TGA) and anti-endomysial antibody (EMA) have been used as adjuncts to biopsy since the 1970's. Previous studies have looked at the correlation between one and a combination of two of these antibodies with the biopsy fi ndings. Many of these studies have reported variable to high sensitivity for one or two antibodies. However, there have been no studies which have assessed the sensitivity and accuracy of measuring all three antibodies and whether doing so would preclude the need for small bowel biopsy. Aim: Th e purpose of this study is to compare the sensitivity and accuracy of measuring all three antibodies to one or a combination of two antibodies and to correlate the results with biopsy fi ndings to determine whether endoscopy can be avoided in the diagnosis of celiac sprue. Methods: Aft er obtaining appropriate institutional approval, a retrospective review of the charts of patients who underwent small bowel biopsies for suspected celiac disease between January 1, 2006 and December 31, 2008 were selected. Th ere were a total of 44 all patients who had all three antibodies checked and EGD done. Th e results of the antibody testing were correlated with the biopsy fi ndings. Results: Th e sensitivity for the diagnosis of celiac sprue when measuring all 3 antibodies was 84.2%. Th is was signifi cantly higher than measuring any of the 3 antibodies individually (p < 0.05; sensitivity for AGA was 77.7%, EMA was 66.6%, and TGA was 70.5%). Further, the accuracy of diagnosis of celiac sprue when measuring all 3 antibodies was 84.6%, signifi cantly higher than measuring antibodies individually (p < 0.05; accuracy for AGA was 63.6%, EGA was 62.9%, and TGA was 70.4%). Conclusion: Our results suggest that when all 3 antibodies are abnormal, this provides more accuracy and sensitivity for the diagnosis of celiac sprue than relying on individual antibodies. With a sensitivity of 84.2% and an accuracy of 84.6%, measuring all 3 antibodies could be useful but might not replace biopsies to diagnose celiac sprue.
Purpose: Subspecialty consultations are an important part of inpatient medical management. Gastrointestinal consultations (GIC) are procedure-intensive, and some of the most requested in the inpatient setting. Recent studies suggest a lack of knowledge on the part of those requesting consultations. Th erefore, we sought to determine the most common indication for inpatient GIC, and procedures/ imaging that might result thereaft er in a large academic teaching hospital. Methods: We conducted a retrospective review of all GIC from January 1st, 2009 until December 31st, 2009 at a single institution. We reviewed the reason for the GIC as determined by the requesting provider and the GI physician of record. All consults were seen within 24 hrs of being called, by a GI Fellow and Attending. A review of all procedures/imaging that resulted in the subsequent 7 days was noted. We recorded demographic information on the consult population. Results: A total of 1733 GIC were requested, 1720 which had complete demographic information. Th e distribution of the gender of male and female patients was 52% and 48% respectively. Patient ethnicity was 80.2% Caucasian, 12.8% African American, 0.5% Asian, and other was 6.5%. Th e most frequent reason for GIC was GI blood loss (25.3%), followed by abdominal pain (20.7%), anemia (12.8%), abnormal liver enzymes (11.6%), abnormal imaging (7.9%) nausea/vomiting (7.9%), diarrhea (6.1%), cirrhosis (5%), odynophagia/dysphagia (4.6%), pancreatitis (3.6%), and infl ammatory bowel disease (3.6%). An average of 4.75 consultations were requested each day, with the average age of the patients being 57.2 years. A large proportion of these patients, 59.8%, underwent a GI procedure within 7 days following the GIC. Th e most common procedure was an EGD (27.1%) followed by Colonoscopy (11%), EGD/ Colonoscopy (8%), ERCP (3.8%), and EUS (2.4%). Conclusion: Recent studies suggest requesting providers have poor knowledge regarding the GIC being requested, despite GI evaluations being one of the most commonly requested. We sought to evaluate our experience as to the indications for GIC being requested, and if it would result in an immediate intervention/procedure. We determined that a majority of patients undergoing a GI consult had a procedure in the following 7 days, and that the most common indications for GI consultation were for GI blood loss/anemia, abnormal liver enzymes, and abnormal imaging. Further investigations are needed in evaluating the utilization, knowledge, and appropriateness of GIC in the inpatient setting in today's changing health care environment.
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Symptom Frequency, Health Care Seeking Behavior, and Satisfaction with Th erapy among Chronic Constipation Patients: Results of a Population-Based Survey Philip Schoenfeld, MD, MSEd, MSc (Epi). University of Michigan, Ann Arbor, MI.
Purpose: Th is is the fi rst population-based study of chronic constipation (CC) patients who meet ROME II criteria for CC. Th is survey quantifi ed: i) the frequency and bothersomeness of gastrointestinal (GI) symptoms; ii) % of suff erers who visited a physician in the past 12 months for GI symptoms; and iii) satisfaction with OTC and prescription therapies and care provided by physicians. Methods: A random sample of 10,030 U.S. citizens completed a ROME II screening questionnaire. Individuals who met ROME II criteria for CC completed a detailed questionnaire about the frequency (days/year) and bothersomeness of individual symptoms (including ranking the 3 most bothersome symptoms), health-care seeking behavior, and medication use. Satisfaction with physician care and GI medications were each rated using a 5-point Likert scale (ranging from "not at all satisfi ed" to "extremely satisfi ed"). Survey responses were weighted to be representative of the U.S. census for age and gender. Individuals with a history of IBD, PUD, diverticulitis, or GI cancers were excluded. Results: 1123 (11.2%) of 10,030 survey participants met ROME II criteria for CC. Of these CC suff erers, 58% were female, 78% were Caucasian, 44% were 18-39 years old, and 16% were ≥ 65 years old. Abdominal discomfort was reported at least once per week by 52%. When asked to identify the presence 
